Neurology
RSSArticles
-
Trauma Reports Supplement
-
The Red Eye
The number of adult ED visits for eye-related complaints is largely limited to data on eye injuries. -
Emergency Medicine Reports - Full June 20 2011 Issue in PDF
-
Pharmacology Watch
Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions. -
Stroke Alert: A Review of Current Clinical Stroke Literature
Crest failed to demonstrate any significant differ-ence in the primary endpoint (composite of stroke, myocardial infarction, or death during the 4-year follow-up period) between carotid artery stenting (CAS) and carotid endarterectomy (CEA) in patients with symptomatic or asymptomatic carotid artery stenosis. -
Common Entrapment Neuropathies and Chronic Inflammatory Demyelinating Neuropathy
Entrapment neuropathies are not more common in the setting of chronic inflammatory demyelinating neuropathy and suggest a surgically treatable lesion. -
REM Sleep Behavior Disorder and Biomarkers of Neurodegenerative Disease
Biomarkers for Parkinson's disease and related neurodegenerative diseases occur frequently in patients with idiopathic REM sleep behavior disorder. These include impairment of olfactory and color discrimination, and abnormalities in cerebral blood flow. -
Neurology Alert - Full July 2011 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Are We Close to Understanding the Role of Fingolimod in the Treatment of MS?
Patients originally on interferon beta-1a in the TRANSFORMS study were re-randomized to either 0.5 or 1.25 mg of fingolimod. There was a reduction in relapse rate and MRI activity in patients that switched to fingolimod without an increase in severe adverse events.